Trials / Active Not Recruiting
Active Not RecruitingNCT05043220
Covid-19 Predictors: Safety of Gynecological Oncology Patients Undergoing Systemic Cancer Therapy
COVID-19-Prädiktoren: Klinische Studie Zur Sicherheit Von Gynäkologisch Onkologischen Patientinnen Unter Onkologischer Systemtherapie - CO-SI-ONKO-Studie
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Technical University of Munich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We designed a monocenter prospective cohort study using PROM via app and remote monitoring via pho-toplethysmography (PPG). The application of these technologies enables an early detection of infections and therefore initiation of medical interventions. The study is conducted as feasibility analysis; primary endpoints are adherence (according to wearing time) and technical robustness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PPG and PROM | description will follow |
Timeline
- Start date
- 2021-09-29
- Primary completion
- 2022-10-31
- Completion
- 2025-04-30
- First posted
- 2021-09-14
- Last updated
- 2024-11-22
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05043220. Inclusion in this directory is not an endorsement.